As of April 29, 2025, Prelude Therapeutics (PRLD) has a market cap of $49.689 million USD. According to our data, Prelude Therapeutics is ranked No.8108 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $49.69 M |
-7.62%
|
Dec 31, 2024 | $53.79 M |
-70.14%
|
Dec 29, 2023 | $0.18 B |
-29.30%
|
Dec 30, 2022 | $0.25 B |
-51.49%
|
Dec 31, 2021 | $0.53 B |
-82.60%
|
Dec 31, 2020 | $3.02 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.71 B |
-0.000 M
|
![]() USA
|
![]() Kura Oncology
KURA
|
$0.53 B |
0.000 M
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.53 B |
0.000 M
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$7.56 B |
-0.000 M
|
![]() USA
|
![]() Zentalis Pharmaceuticals
ZNTL
|
$98.38 M |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
-0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Arcus Biosciences
RCUS
|
$0.86 B |
-0.000 M
|
![]() USA
|
![]() Gossamer Bio
GOSS
|
$0.20 B |
-0.000 M
|
![]() USA
|
![]() Repare Therapeutics
RPTX
|
$56.11 M |
0.000 M
|
![]() Canada
|
Market Cap | = | PRLD Stock Price | * | PRLD Shares Outstanding |
= | $0.90 | * | 42.30 M | |
= | $49.69 M |